دانلود مقالات ISI درباره Velaglucerase Alfa + ترجمه فارسی

توسعه آنتیبادیهای ضد ویگللوسروز آلفا در بیماران تحت درمان با بیمار مبتلا به بیماری گوچه

Development of anti-velaglucerase alfa antibodies in clinical trial-treated patients with Gaucher disease

Keywords: ADA; anti-drug antibody; AE; adverse event; CCL18; chemokine (C-C motif) ligand 18; ECL; electrochemiluminescence; ELISA; enzyme-linked immunosorbent assay; ERT; enzyme replacement therapy; GD; Gaucher disease; RIP; radioimmunoprecipitation; TEAE; treatme

دانلود رایگان متن کامل مقاله ISI 7 صفحه سال انتشار : 2016 سفارش ترجمه

تأثیر واژلاسیسراز آلفا بر میزان باروری مغز استخوان در بیماران بزرگسال مبتلا به نوع 1 گوچه: پیگیری 7 ساله

Impact of velaglucerase alfa on bone marrow burden score in adult patients with type 1 Gaucher disease: 7-Year follow-up

Keywords: BL; baseline; BMB; bone marrow burden; BMD; bone mineral density; CCL18; chemokine (C-C motif) ligand 18; EOW; every other week; ERT; enzyme replacement therapy; F; femur; F-BMB; femoral bone marrow burden; FN; femoral neck; GD; Gaucher disease; LS; lum

دانلود رایگان متن کامل مقاله ISI 5 صفحه سال انتشار : 2014 سفارش ترجمه

Reductions in glucosylsphingosine (lyso-Gb1) in treatment-naïve and previously treated patients receiving velaglucerase alfa for type 1 Gaucher disease: Data from phase 3 clinical trials

Keywords: β-GC; β-glucocerebrosidase; CCL18; chemokine (C-C motif) ligand 18; ERT; enzyme replacement therapy; GD; Gaucher disease; lyso-Gb1; glucosylsphingosine; MN; multiples of normal; Gaucher disease; Glucosylsphingosine; Lyso-Gb1; Velaglucerase alfa; Enzyme

دانلود رایگان متن کامل مقاله ISI 8 صفحه سال انتشار : 2017 سفارش ترجمه

Stability is maintained in adults with Gaucher disease type 1 switched from velaglucerase alfa to eliglustat or imiglucerase: A sub-analysis of the eliglustat ENCORE trial

Keywords: Composite endpoint; Eliglustat; Gaucher disease type 1; Imiglucerase; Non-inferiority trial; Velaglucerase alfa;

دانلود رایگان متن کامل مقاله ISI 4 صفحه سال انتشار : 2016 سفارش ترجمه

Evaluation of treatment response to enzyme replacement therapy with Velaglucerase alfa in patients with Gaucher disease using whole-body magnetic resonance imaging

Keywords: Velaglucerase alfa; Whole-body MRI; Score systems; Gaucher disease;

دانلود رایگان متن کامل مقاله ISI 7 صفحه سال انتشار : 2016 سفارش ترجمه

13,845 home therapy infusions with velaglucerase alfa exemplify safety of velaglucerase alfa and increased compliance to every-other-week intravenous enzyme replacement therapy for Gaucher disease

Keywords: Gaucher disease; Home therapy; Intravenous administration; Quality of life; Safety; Velaglucerase alfa

دانلود رایگان متن کامل مقاله ISI 4 صفحه سال انتشار : 2015 سفارش ترجمه

Booster-effect with velaglucerase alfa in patients with Gaucher disease switched from long-term imiglucerase therapy: Early Access Program results from Jerusalem

Keywords: Gaucher disease; Enzyme replacement therapy; Imiglucerase; Velaglucerase alfa; Switch-over

دانلود رایگان متن کامل مقاله ISI 6 صفحه سال انتشار : 2012 سفارش ترجمه

Development of a panel of highly sensitive, equivalent assays for detection of antibody responses to velaglucerase alfa or imiglucerase enzyme replacement therapy in patients with Gaucher disease

Keywords: ADA; anti-drug antibody; BSA; bovine serum albumin; CPM; counts per minute; DPBS; Dulbecco's Phosphate Buffered Saline solution; ECL; electrochemiluminescence; EMA; European Medicines Agency; FDA; Food and Drug Administration; HBS-EP; HEPES-buffered salin

دانلود رایگان متن کامل مقاله ISI 9 صفحه سال انتشار : 2011 سفارش ترجمه